Middle East Cystic Fibrosis Association MECFA

MECFA Blog

Arch Scientist Publishes Data on the Pre-Clinical Efficacy of AB569 in Killing of Drug Resistant Bac

TORONTO, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., ("Arch" or the "Company") (TSXV:ARCH, OTCQB:ACHFF), announced today...

Cystic Fibrosis And Infertility

Although, cystic fibrosis does not have any permanent,-cure, prevention can reduce the severity of complications Cystic fibrosis is a...

How cystic fibrosis can manifest in the gastrointestinal system

In the February 2020 issue of Contemporary Pediatrics, Drs. Anna Reed and Darla Shores provide a briefing on the care of cystic fibrosis...

New X-Ray Technology For Better Management Of Lung Diseases

Australia: Researchers at Monash University have developed radical non-invasive X-ray technology to help diagnose, treat and manage...

Noninvasive XV Technology May Lead to Faster CF Diagnosis and Better Treatment

A new non-invasive tool, called XV technology, allows professionals to visualize airflow in a living lungs and could help in the...

Arrevus Receives FDA Orphan Drug Designation for ARV-1801 (sodium fusidate)

Arrevus, a clinical stage biopharmaceutical company committed to the development of innovative therapies to treat orphan or serious...

Synspira Therapeutics, CF Foundation Agree to Support Development of SNSP003 for Malabsorption Syndr

The Cystic Fibrosis Foundation has reached an agreement with Synspira Therapeutics to support the further development of SNSP003, an...

Desaturation during exercise is not a sufficient mechanism for prediction of osteoporosis in non-cys

Recent research has proposed an association between desaturation during a six minute walking test (6MWT) and osteoporosis in an elderly...

Researchers describe unique genetic identity of primordial lung progenitors Findings may lead to bet

(Boston)--For the first time, researchers describe the genetic program behind primordial lung progenitors--embryonic cells that give rise...

Study Describes Genetic Mechanisms Behind Embryonic Lung Cells

The researchers hope the findings could one day lead to cell replacement therapies for respiratory diseases, including chronic...

Disease Duration, Flare-ups Affect Mental Health of Non-CF Bronchiectasis Patients, Study Finds

VERTEX’S CF BLOCKBUSTER TRIKAFTA EFFECTIVE IN KIDS 6 TO 11 YEARS OF AGE

A case for improved carrier screening

Vertex to Seek Expanded FDA Approval for Trikafta After Positive Child Safety Data

Vertex’s Kaftrio approved for use in Europe and made accessible on the NHS

Age May Affect Outcomes in Lung Transplant Recipients With Cystic Fibrosis

CFF Funding Will Further ContraFect’s Research Into Alternative for Antibiotics

The search for molecular glue in targeted disease control

Vest Therapy Lowers Risk of Hospitalization in Non-CF Bronchiectasis, Study Says

Harvard is working with Boston hospitals to test existing cystic fibrosis drug to help coronavirus p